Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria

NCT04383535 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.

NCT NCT04383535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria
Lead sponsor
Hospital Italiano de Buenos Aires
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2020
Completion date
September 27, 2020
Enrollment
333 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars virus, sars-cov-2